Categories Earnings, LATEST, Other Industries
Earnings: Alcoa slips to Q2 loss as low demand hurts sales; stock falls
Alcoa Corporation (NYSE: AA), a leading manufacturer of aluminum products, reported a net loss for the second quarter compared to profit last year, reflecting a sharp fall in revenues amid faltering demand and lower prices. The bottom-line, however, came in above the consensus estimate.
On an adjusted basis, Alcoa reported a net loss of $0.01 per share for the June quarter, compared to earnings of $1.17 per share in the corresponding period of 2018. Analysts were looking for a wider loss. Unadjusted net loss was $402 million or $2.17 per share, compared to a profit of $10 million or $0.05 per share in the second quarter of last year.
Sales Falter
Revenues declined 24% annually to $2.7 billion and came in broadly in line with the estimates. The top line was negatively impacted by lower demand for aluminum and alumina and unfavorable pricing.
Roy Harvey, chief executive officer of Alcoa, said, “In the second quarter, our Aluminum segment rebounded despite weaker metal prices, and we reported a solid cash balance, even after sizeable cash outlays. We also maintained strong operational performance across all of our businesses.”
Looking Ahead
For the current fiscal year, Alcoa predicts annual bauxite shipments to be 47-48million dry metric tons. Total alumina shipments are expected to be between 13.6 million and 13.7 million metric tons, while aluminum shipments are forecast to be between 28 million and 29 million metric tons.
Related: Alcoa Inc. Q1 2019 Earnings Conference Call Transcript
Of late, Alcoa has been facing multiple challenges, including low demand for its products and uncertainties from the US-China trade dispute. The management has predicted that the global demand for aluminum will remain sluggish throughout the year. The oversupply of alumina in the Atlantic Basin is one of the reasons behind the slump.
Stock Performance
Alcoa is one of the worst-performing Wall Street stocks, which has been on a losing streak for the past two years. It lost about 22% in the past six months and 12% since last year. The stock closed Wednesday’s regular session notably lower and continued to lose in the after-hours session.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on